StocksMedium•10 November 2026•
1 min read
CalciMedica Reports Narrower-Than-Expected Q3 Loss
Key Facts
1CalciMedica reported a GAAP EPS of -$0.24, beating analyst estimates by $1.03.
CalciMedica reported a GAAP loss per share of $0.24 for the third quarter of 2026. Seeking Alpha reported that these results beat analyst estimates by $1.03, representing a significantly narrower loss than anticipated for the fiscal period ending September 2026.
The company held cash, cash equivalents, and short-term investments totaling $13.8 million as of September 30, 2026. In equity markets, CALC closed at $1.52 on November 9, 2026, after trading between a session low of $1.39 and a high of $1.61.